Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 26.3B | 25.9B | 29.6B | 31.1B |
Cost of revenue | 20.1B | 19.4B | 21.8B | 22.7B |
Gross profit | 6.3B | 6.5B | 7.8B | 8.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 4.2B | 4.5B | 4.6B | 4.6B |
Other operating expenses | 7M | 19M | 105M | 2M |
Operating income | 2.1B | 2.8B | 3.1B | 3.8B |
Non operating interest income | ||||
Income | 607M | 181M | 379M | 1.1B |
Expense | 84M | 550M | 38M | 42M |
Other income expense | — | — | — | — |
Pretax income | 2.7B | 2.4B | 3.5B | 4.8B |
Tax provision | -3M | 363M | 1.1B | 1.4B |
Net income | 2.7B | 2.0B | 2.3B | 3.4B |
Basic EPS | — | 166.6 | 194.0 | 284.9 |
Diluted EPS | — | 166.6 | 194.0 | 284.7 |
Basic average shares | — | 12.1M | 12.1M | 12.1M |
Diluted average shares | — | 12.1M | 12.1M | 12.1M |
EBITDA | 4.3B | 4.4B | 5.0B | 6.3B |
Net income from continuing op. | 2.7B | 2.4B | 3.5B | 4.8B |
Minority interests | -1M | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |